The HTRA1 gene makes a protein that helps control protein cleanup and maintain the structure of tissues, especially in blood vessel walls. This gene plays an important role in keeping small blood vessels and surrounding support tissue working normally. If it does not work properly, some people can develop an inherited small vessel condition that may lead to stroke, balance or walking problems, memory changes, back pain, or early hair thinning. Effects can vary widely depending on the specific variant.
What is a gene?
Genes are segments of DNA that carry instructions your cells use to make molecules or regulate processes in the body. Some genes provide the information needed to produce proteins, which are the working parts of cells. Other genes mainly help determine when certain processes happen, where they take place, and how strongly they occur. Taken together, genes affect how the body develops and functions, and they can influence how you respond to food, stress, or medications. For a deeper look at this topic, you can find more in the LearnHub.
Overview
HTRA1Gene function
What if the gene works
The HTRA1 gene helps cells clear worn out proteins and manage the supportive material around them. This helps maintain healthy blood vessels, the retina, and other tissues.
Risk
What if the gene does not work
Variants in the HTRA1 gene can cause inherited small blood vessel disease in the brain, with stroke and thinking changes. Some severe variants also bring hair loss and back pain, and effects can range from mild to severe.
Treatment
What does that mean for your treatment
No treatment or management approach specific to the HTRA1 gene is currently established. Care follows standard treatment for a person’s symptoms and complications. The HTRA1 gene is also being studied as a possible drug target in age related macular degeneration, but this has not changed routine care.
Conditions associated with HTRA1
Gene function
What if the gene works
The HTRA1 gene helps your body manage the protein rich space around cells. It makes an enzyme that cuts selected proteins, which supports routine tissue upkeep and cell signaling. This gives a practical picture of what the HTRA1 gene does in the body each day.
The HTRA1 gene helps make an enzyme that clips worn out or extra proteins into smaller pieces. This cleanup supports the space around cells and helps keep proteins from collecting where they are no longer needed.
Its enzyme also trims parts of the material that surrounds cells, helping tissues renew and maintain their structure. This steady remodeling is part of normal upkeep in connective tissue and blood vessel walls.
HTRA1 also helps fine tune signals such as TGF-beta, a messenger that guides growth and repair. Balanced signaling helps cells respond to everyday stress in a more organized way.
What is a variant?
A genetic variant is a minor change in the DNA sequence within a gene. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, and the way the body responds to environmental influences. Many variants do not cause any noticeable effect and simply represent natural genetic variation. At times, though, a variant can change how a gene works to a greater extent and may contribute to or lead to a genetic condition.
Genetic variants
What if the gene does not work
Many variants in the HTRA1 gene alter the protein’s shape, stability, or release, which can reduce or abolish its enzyme activity. Understanding how variants in the HTRA1 gene affect protein function helps explain why some changes are milder, while others can also interfere with the protein made from the other copy. Variants affecting both copies often cause the largest loss of function and are linked to earlier, broader small blood vessel disease than some single-copy variants.
How variants are linked to conditions
Pathogenic variants in the HTRA1 gene are linked to inherited cerebral small vessel disease, a condition that can lead to stroke, walking problems, mood changes, and white matter changes on brain scans. One altered copy can cause HTRA1-related cerebral small vessel disease, while two altered copies can cause CARASIL, a rarer condition that often starts earlier and may also include back pain and hair loss. This means HTRA1 gene variants linked to stroke and white matter disease are clinically important when doctors evaluate a strong family pattern of these findings.
A variant is not necessarily a diagnosis
Variants in genes are a routine part of human biology and are common across the general population. Most do not have a direct effect on health and simply contribute to natural human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some situations, however, a single well-characterized variant in a specific gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For many living with an HTRA1 change, the gene variant itself is the main reason risk is higher, especially for blood vessel disease in the brain. High blood pressure, smoking, diabetes, and high cholesterol can add to the chance of stroke or worsening symptoms. Keeping these under control can help lower the risk of complications.
Inheritance of HTRA1 variants
The HTRA1 inheritance pattern depends on the specific HTRA1-related condition. Some variants in the HTRA1 gene are inherited in an autosomal recessive way, which means a child must inherit one changed copy from each parent. Other variants are inherited in an autosomal dominant way, which means one changed copy from either parent can be enough to cause the condition. In families with a dominant HTRA1 gene variant, each child of an affected parent has a 50% chance of inheriting that variant.
What does my HTRA1 result mean for my family?
HTRA1 can be linked to more than one inherited condition, so what it means for relatives depends on the exact result. Some HTRA1 changes are tied to a dominant form of small blood vessel disease in the brain, where close family members may also carry the change and may wish to discuss testing. Other HTRA1 changes cause a recessive condition, which means relatives may be healthy carriers without symptoms.
Genetic information
Genetic testing
How you find out about variants
To find out about HTRA1 variants, genetic testing usually analyzes DNA from a blood or saliva sample. A lab reads the HTRA1 gene to look for variants and reports whether a change is present, absent, or not yet clearly understood.
When should I consider getting a genetic test?
Genetic testing for the HTRA1 gene may be worth considering if you or close relatives have had strokes, worsening balance or thinking problems, or brain scan changes from small blood vessel disease at a younger age than expected. It can also help explain a family pattern of these problems, sometimes with early hair loss or back pain.
A genetic result is only one part of your health story
Genetic findings can offer useful insight, but how much they explain varies by the condition and the type of variant involved. Many factors also shape how the body works over time, including lifestyle, environment, age, and medical history. In some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result can give a clear answer. In areas like medication response, genetic results can also help put personal experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Two people can take the same treatment, yet one may get better benefit while the other notices less effect or more side effects. Part of this difference comes from inherited changes that influence how the body absorbs, breaks down, or reacts to a drug. These genetic differences are common and are one reason medication response can vary from person to person.
What is Pharmacogenetics?
Pharmacogenetics is the area of study that examines how differences in genes can affect the way a person responds to medicine. It focuses on gene drug patterns to help explain why the same treatment may work differently in different people. For many medicines, genes can influence how powerfully a drug works or how the body handles it. This information can support treatment decisions that are more informed and more individualized. More detail on this topic is available in the LearnHub.
Drugs influenced by the HTRA1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medicine choice or dose, so general medication questions are best discussed with your doctor. Some studies have explored whether HTRA1 changes may affect response to certain treatments for age-related macular degeneration, but this has not become standard care.
History
The HTRA1 gene entered medical genetics through two different stories that later came together. In the 1990s, researchers identified HTRA1 as part of a family of genes related to an older bacterial stress response pathway. A major shift came in the 2000s, when studies linked changes in the chromosome 10q26 region near HTRA1 to age related macular degeneration, a common cause of vision loss in older adults. From these first observations, research expanded steadily. Around the same time, rare harmful variants in the HTRA1 gene were shown to cause CARASIL, an inherited condition affecting the brain’s small blood vessels. As medical science evolved, the picture became clearer, especially as scientists worked out how HTRA1 and the nearby ARMS2 gene each contributed to early findings.